Insider Transactions in Q3 2022 at Oak Street Health, Inc. (OSH)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.34%
|
$1,300,000
$26.3 P/Share
|
|
Sep 16
2022
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
838,496
-2.5%
|
$20,123,904
$24.72 P/Share
|
|
Sep 08
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.34%
|
$1,350,000
$27.17 P/Share
|
|
Sep 06
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.8%
|
$1,000,000
$25.32 P/Share
|
|
Sep 01
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.43%
|
$250,000
$25.7 P/Share
|
|
Aug 25
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.0%
|
$1,400,000
$28.95 P/Share
|
|
Aug 23
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.75%
|
$1,000,000
$25.9 P/Share
|
|
Aug 19
2022
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
7,000,000
-17.28%
|
$168,000,000
$24.72 P/Share
|
|
Aug 17
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.42%
|
$250,000
$26.0 P/Share
|
|
Aug 11
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.5%
|
$1,450,000
$29.46 P/Share
|
|
Aug 11
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15
-0.0%
|
$435
$29.32 P/Share
|
|
Aug 10
2022
|
Brian Clem Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
7,700
-1.29%
|
-
|
|
Aug 09
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-3.35%
|
$1,160,000
$29.08 P/Share
|
|
Aug 08
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
100,729
-7.78%
|
$3,021,870
$30.48 P/Share
|
|
Aug 05
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
45,794
-3.42%
|
$1,373,820
$30.12 P/Share
|
|
Aug 04
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
53,366
-3.83%
|
$1,600,980
$30.01 P/Share
|
|
Aug 03
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,176
-0.04%
|
$95,280
$30.3 P/Share
|
|
Aug 03
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
2,600
-0.19%
|
$78,000
$30.24 P/Share
|
|
Aug 02
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
157,534
-2.14%
|
$4,726,020
$30.03 P/Share
|
|
Aug 02
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
147,511
-9.56%
|
$4,425,330
$30.03 P/Share
|
|
Aug 02
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
40,000
-6.28%
|
$1,200,000
$30.0 P/Share
|
|
Jul 28
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
200,000
-1.91%
|
$5,600,000
$28.77 P/Share
|
|
Jul 28
2022
|
Geoffrey M Price Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+0.09%
|
-
|
|
Jul 26
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-2.53%
|
$1,080,000
$27.97 P/Share
|
|
Jul 20
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
150,000
-8.65%
|
$3,150,000
$21.2 P/Share
|
|
Jul 12
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
62,800
-1.75%
|
$1,381,600
$22.67 P/Share
|